The invention relates to compounds of formula: 1
and to solvates and/or hydrates thereof, with affinity for and selectivity
towards the V.sub.1b receptors or both the V.sub.1b and V.sub.1a
receptors of arginine-vasopressin.
The invention also relates to a process for preparing them, to the
intermediate compounds of formula (II) which are useful for preparing
them, to pharmaceutical compositions containing them and to their use for
preparing medicinal products.
